Journals / Epilepsi / 2018 / Cilt: 24 - Sayı: 1

Effects of Medication Adherence in Epilepsy Patients On Quality of Life

Epilepsi Hastalarında İlaç Tedavisine Uyumun Yaşam Kalitesi Üzerine Etkileri

Journal
Epilepsi
Pages
8–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We recommend making efforts to eliminate the negativity, if there is any, and to increase the quality of life by evaluating the factors that may influence drug compliance in patients on an individual basis considering low drug compliance therefore low quality of life groups.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aimed to observe epileptic patients on drug compliance and its effects on their quality of life to reveal the effects of socio-demographic and disease-related characteristics on drug compliance and quality of life.
📊
Key Findings & Data:Methods: This study was performed with self-filling and face-to-face interview method with 84 epileptic patients, who were selected by a random sampling method from those who applied to GATA Haydarpaşa Training Hospital, Neurology Polyclinic, between January and June 2014.
💡
Conclusion & Impact:Conclusion: We recommend making efforts to eliminate the negativity, if there is any, and to increase the quality of life by evaluating the factors that may influence drug compliance in patients on an individual basis considering low drug compliance therefore low quality of life groups.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aimed to observe epileptic patients on drug compliance and its effects on their quality of life to reveal the effects of socio-demographic and disease-related characteristics on drug compliance and quality of life. Methods: This study was performed with self-filling and face-to-face interview method with 84 epileptic patients, who were selected by a random sampling method from those who applied to GATA Haydarpaşa Training Hospital, Neurology Polyclinic, between January and June 2014. When data related to patients were collected, an introductive patient interview form, which contains information about the disease, the Morisky Medication Adherence Scale, indicating drug compliance, and the short form-36 scale, which measures quality of life, were used. Results: Patients with a high drug compliance were found to have significantly higher scores on emotional role (p<0.043), viability (p<0.000), mental health (p<0.002), and general health (p<0.000). Conclusion: We recommend making efforts to eliminate the negativity, if there is any, and to increase the quality of life by evaluating the factors that may influence drug compliance in patients on an individual basis considering low drug compliance therefore low quality of life groups.

Özet

Amaç: Bu çalışma, epilepsili hastaların ilaç tedavisine uyumu ve bunun hastaların yaşam kalitesi üzerine etkilerini incelemek, sosyo-demografik ve hastalığa ilişkin özelliklerin ilaç uyumu ve yaşam kalitesi üzerine etkilerini ortaya koymak amacıyla yapıldı. Gereç ve Yöntem: Çalışma Ocak 2014–Haziran 2014 tarihleri arasında, GATA Haydarpaşa Eğitim Hastanesi Nöroloji Polikliniği’ne başvuran rastgele örneklem yöntemiyle seçilmiş 84 epilepsili hasta ile kendi kendine form doldurma ve yüz yüze görüşme yöntemi ile gerçekleştirildi. Hastalarla ilgili veriler toplanırken; tanıtıcı ve hastalıkla ilgili bilgileri içeren hasta görüşme formu, ilaç uyumunu gösteren Morisky uyum ölçeği ve kısa form-36 (SF-36) yaşam kalitesi ölçeği kullanıldı. Bulgular: Sonuçlar değerlendirildiğinde; yüksek ilaç uyumuna sahip hastaların yaşam kalitesi ölçeğine göre, duygusal rol (p<0.043), canlılık (p<0.000), ruhsal sağlık (p<0.002), genel sağlık (p<0.000) bakımından anlamlı ölçüde daha yüksek skorlara sahip olduğu tespit edildi. Sonuç: İlaç uyumu ve dolayısıyla yaşam kalitesi düşük gruplar göz önünde bulundurularak hastalarda ilaç uyumuna etki edebilecek faktörlerin birey bazında değerlendirilerek, varsa olumsuzlukların giderilmesi ve yaşam kalitesinin artırılmasına yönelik çalışmalar yapılmasını öneriyoruz.

🔖

Cite This Article

GÜLAY, B., KENDİRLİ, M. T., DEMİR, S., SONKAYA, A. R., ÖZDAĞ, M. F. (2018). Effects of Medication Adherence in Epilepsy Patients On Quality of Life. Epilepsi, Cilt: 24 - Sayı: 1, 8–14. https://ajindex.com/articles/153566

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology 2007;68(5):326–37.
  2. Guekht AB, Mitrokhina TV, Lebedeva AV, Dzugaeva FK, Milchakova LE, Lokshina OB, et al. Factors influencing on quality of life in people with epilepsy. Seizure 2007;16(2):128–33. Devinsky O. Clinical uses of the quality-of-life in epilepsy inventory. Epilepsia 1993;34 Suppl 4:S39–44. Devinsky O, Baker G, Cramer J. Quantitative Measures of Assesment. In: Engel J, Pedley TA, editors. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1997. p. 1107–13.
  3. Devinsky O, Vickrey BG, Cramer J, Perrine K, Hermann B, Meador K, et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995;36(11):1089–104. Meeberg GA. Quality of life: a concept analysis. J Adv Nurs 1993;18(1):32–8.
  4. Padilla GV, Grant MM, Ferrell B. Nursing research into quality of life. Qual Life Res 1992;1(5):341–8.
  5. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67–74. Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med 1990;88(1):253–6.
  6. Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol 2012;11(9):792–802.
  7. Alanis-Guevara I, Peña E, Corona T, López-Ayala T, López-Meza E, López-Gómez M. Sleep disturbances, socioeconomic status, and seizure control as main predictors of quality of life in epilepsy. Epilepsy Behav 2005;7(3):481–5.
  8. Baker GA, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res 1998;30(3):231–40.
  9. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38(3):353–62.
  10. Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999;53(1):162–6.
  11. Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet 2012;380(9848):1193–201. Devinsky O. Definition and overview of intractable epilepsy. In: Schachter SC, Schomer DL, editors. The comprehensive evaluation and treatment of epilepsy: a practical guide. San Diego: San Diego Academic Press; 1997. p. 86–7. Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000;20(8 Pt 2):191S–9. Devinsky O. Patients wit